ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988

Community-Based Program Final Planning Review In August, October

August 6, 1976

CCOP Recompetition Approved By NCAB

May 23, 1986

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984

New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds”

March 18, 1983